Comparison Of Effectiveness of Mobilization With Movement (MWM) and Kelternborn Treatment Technique to Increase ROM, Reducing Pain in Patient of ACL Reconstruction

May 23, 2023 updated by: Muhammad Naveed Babur, Superior University
To determine the Comparison Of Effectiveness of Mobilization With Movement (MWM) and Kelternborn Treatment Technique to Increase ROM, Reducing Pain in Patient of ACL Reconstruction

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan
        • Recruiting
        • Superior University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Subjects with age group between 20 to 60 years with sedentary lifestyle were included.

    • Both males and females were included.
    • Patients with diagnosed Tight hamstrings having knee extension less than 160º with the hip at 90º flexion.
    • Patients with decreased ROM at the knee joint.
    • Patients with reduced straight leg raise.
    • Patients with pain in posterior compartment of thigh.
    • Asymptomatic patients will be included.

Exclusion Criteria:

  • • Patients with prolapsed disc were excluded.

    • Patients with lower extremity injuries (strain, sprain, ligament injuries, etc.) in last 6 months were excluded.
    • Patients with severe hamstring injury either acute or chronic were excluded.
    • Patients with visual acute swelling in the region of hamstring muscle
    • Patients with fracture of any type and area.
    • Patients with dislocations or subluxations present were excluded.
    • Patient recommended for TKR of knee joint.
    • Patients with any neurological disease like lumbar/cervical herniation, polyneuropathy, scoliosis etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Mobilization With Movement (MWM)
Diagnostic test: Mobilization With Movement (MWM)
Mobilization With Movement
Experimental: Kelternborn Treatment Technique
Diagnostic test: Kelternborn Treatment Technique
Kelternborn Treatment Technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Goniometer (Range of Motion)
Time Frame: 6 Months
6 Months
Visual Analog Scale ( VAS)
Time Frame: 6 Months
6 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

August 1, 2023

Study Registration Dates

First Submitted

March 18, 2023

First Submitted That Met QC Criteria

May 23, 2023

First Posted (Actual)

May 24, 2023

Study Record Updates

Last Update Posted (Actual)

May 24, 2023

Last Update Submitted That Met QC Criteria

May 23, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • DPT/Batch-Fall18/539

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe